Related Experiment Video
Updated: Oct 25, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Ectopic Calcification and Hypophosphatemic Rickets: Natural History of ENPP1 and ABCC6 Deficiencies
Carlos R Ferreira1, Kristina Kintzinger2, Mary E Hackbarth1
1National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
Insights
Generalized arterial calcification of infancy (GACI) has high early mortality, with bisphosphonates showing no survival benefit. ENPP1 variants are linked to higher mortality and rickets, suggesting ARHR2 is part of the ENPP1 deficiency spectrum.
Area of Science:
- Genetics
- Pediatrics
- Mineral Metabolism
Background:
- Generalized arterial calcification of infancy (GACI) is a rare, severe disorder.
- It is caused by variants in the ENPP1 or ABCC6 genes.
- GACI presents with arterial calcification, low pyrophosphate, and high early mortality.
Purpose of the Study:
- To investigate the natural course of GACI.
- To compare outcomes between ENPP1 and ABCC6 deficiencies.
- To clarify the relationship between GACI, ENPP1 deficiency, and autosomal recessive hypophosphatemic rickets type 2 (ARHR2).
Main Methods:
- Retrospective review of 247 GACI patient records from 19 countries.
- Analysis of mortality, clinical phenotypes, and treatment effects.
- Genetic analysis to identify causative variants.
Main Results:
- Overall GACI mortality is 54.7%, with a critical period before 6 months.
- Bisphosphonate treatment showed no significant survival benefit.
- ENPP1 deficiency is associated with higher mortality (40.5%) and rickets (70.8%) compared to ABCC6 deficiency (10.5% and 11.8%, respectively).
- Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) is part of the ENPP1 deficiency spectrum, not a distinct condition.
Conclusions:
- GACI carries a significant early mortality risk, irrespective of bisphosphonate treatment.
- ENPP1 deficiency presents with a distinct phenotype including higher mortality and a high prevalence of rickets.
- ARHR2 should be considered within the spectrum of ENPP1 deficiency, highlighting overlapping pathologies in ectopic calcification disorders.
Abstract:
Generalized arterial calcification of infancy (GACI) is a rare disorder caused by ENPP1 or ABCC6 variants. GACI is characterized by low pyrophosphate, arterial calcification, and high mortality during the first year of life, but the natural course and possible differences between the causative genes remain unknown. In all, 247 individual records for patients with GACI (from birth to 58.3 years of age) across 19 countries were reviewed. Overall mortality was 54.7% (13.4% in utero or stillborn), with a 50.4% probability of death before the age of 6 months (critical period). Contrary to previous publications, we found that bisphosphonate treatment had no survival benefit based on a start-time matched analysis and inconclusive results when initiated within 2 weeks of birth. Despite a similar prevalence of GACI phenotypes between ENPP1 and ABCC6 deficiencies, including arterial calcification (77.2% and 89.5%, respectively), organ calcification (65.8% and 84.2%, respectively), and cardiovascular complications (58.4% and 78.9%, respectively), mortality was higher for ENPP1 versus ABCC6 variants (40.5% versus 10.5%, respectively; p = 0.0157). Higher prevalence of rickets was reported in 70.8% of surviving affected individuals with ENPP1 compared with that of ABCC6 (11.8%; p = 0.0001). Eleven affected individuals presenting with rickets and without a GACI diagnosis, termed autosomal recessive hypophosphatemic rickets type 2 (ARHR2), all had confirmed ENPP1 variants. Approximately 70% of these patients demonstrated evidence of ectopic calcification or complications similar to those seen in individuals with GACI, which shows that ARHR2 is not a distinct condition from GACI but represents part of the spectrum of ENPP1 deficiency. Overall, this study identified an early mortality risk in GACI patients despite attempts to treat with bisphosphonates, high prevalence of rickets almost exclusive to ENPP1 deficiency, and a spectrum of heterogenous calcification and multiple organ complications with both ENPP1 and ABCC6 variants, which suggests an overlapping pathology. © 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR). This article has been contributed to by US Government employees and their work is in the public domain in the USA.
Related Concept Videos
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Introduction to Electrolytes
Role of Sodium
One...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Cell Specific Gene Expression
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

